Enzo Biochem, Inc. (ENZ)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
2.9400-0.0200 (-0.68%)
As of 3:18PM EDT. Market open.
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 2.9600 |
| Open | 2.9000 |
| Bid | 2.9300 x 800 |
| Ask | 2.9600 x 800 |
| Day's Range | 2.9100 - 2.9940 |
| 52 Week Range | 1.8000 - 4.8500 |
| Volume | 90,433 |
| Avg. Volume | 1,225,098 |
| Market Cap | 141.792M |
| Beta (5Y Monthly) | 0.90 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
View moreRelated Research
- CorpGov.com
Roumell Asset Management Sends Letter to Enzo Biochem On Co-Founder’s Resignation
By Jarrett Banks Roumell Asset Management LLC filed an amended 13D on Enzo Biochem Inc. expressing its disapproval that the company hasn’t accepted Co-Founder Elazar Rabbani’s board resignation. Enzo Biochem, Inc., founded in the 1970s, has frustrated investors with a poor operational and share-price performance over the last several years. CorpGov has covered the story extensively. “Shareholders demonstrated […]
- Simply Wall St.
Enzo Biochem's(NYSE:ENZ) Share Price Is Down 41% Over The Past Three Years.
Enzo Biochem, Inc. ( NYSE:ENZ ) shareholders should be happy to see the share price up 26% in the last quarter. But...
- TheStreet.com
Enzo Biochem Blasts Higher as Revenue Jumps 62%
Enzo Biochem registered $31.5 million in sales in the latest quarter, up from $19.4 million last year, and earnings swung to a gain from a loss.
© 2021 Verizon Media. All rights reserved.
